So this doctor would be weighing up the 'possibility' of hyperinsulinaemia against the benefit of insulin therapy. My point is that the 'possibility' element of that scenario could be eliminated by the use of further testing. Of course, in the interim, insulin would be the best treatment and especially in emergency situations.
Every treatment decision doctors make is supposed to involve weighing up the pros and cons.
I don't know what the cost of the insulin testing is but let's assume hypothetically it costs the government 50 GBP, which isn't too far off what other lab tests cost. The cost of lab tests varies widely from say 15 GBP to 500 GBP. The whole cost must be counted, not just the machine running the batch tests. The sample taker, admins, transport, overheads, regulatory compliance etc.
Some in this thread are saying they would never consent to insulin therapy without having this test. That's their choice and I have no problem with that. I like my choices to be respected, too.
I think that the reason this test isn't used for this purpose by the NHS and comparable govt systems in other countries is as follows. (Please respond to the whole scenario rather than just one part of it thanks. That was an issue in a post above in the thread.)
The NICE and other guidelines ask doctors to assess treatment options when an HbaA1c result is above the agreed target range.
Personally, I ask my doctors to agree that the top of my target range is 42. Others could choose 48, or 55, or 65. (The NZ guidelines say 55 is a good threshold to aim for. They also say intensification should be offered at 65, and that it may include insulin or other meds.)
The first step in T2 is to treat high BG with dietary changes alone or with dietary changes + one drug.
3 months later, if the HbA1c is the same or higher, doctors are asked to review the dietary changes and advise, and to consider adding a drug or changing the drugs. (IIRC)
At the 6 month point, if the HbA1c is the same or higher, the doctor is asked to again consider changing and/or adding to the drug regime, and/or adding insulin.
I think the medical consensus for the population as a whole, is that at this point, the risk of hyperinsulinaemia would be low compared to the reality that the patient has had a high HbA1c for at least 6 months, usually more, and the probability of complications and risk to life must be viewed as high priority issue in the decision.
If hyperinsulinaemia were to develop, that could be addressed by reducing or stopping insulin if necessary. I think the number of such cases is likely to be small, but I have not looked for the data on this.
Now, if an insulin level test were to be required at this point of the doctor's decision process, it would cost the taxpayer quite a lot, given the large number of people having the test. If a test adds enough value to a decision making process, then it is worthwhile and not to test would be "false economy."
IMO a doctor can make a safe and appropriate decision to offer a trial of insulin in such a scenario without necessarily using this test. Any doctor prescribing a drug or insulin is legally required to follow up with monitoring and regular consultations with a nurse or a doctor. In this way, the doctor can manage the risk of negative effects.
Having said that, I believe that if a private laboratory wishes to offer this test, it should be free to do so. One of the personal values I hold most dear is the freedom to choose whatever medical tests or interventions I want. I have wasted thousands of dollars doing this, but it is good to have the options.